Home
>
US Stocks
>
Arcutis Biotherapeutics Inc
Arcutis Biotherapeutics Inc
ARQT

Arcutis Biotherapeutics Inc (ARQT)

$21.092.63%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$21.78
Today Low/High$21.09 / $21.97
52 Week Low/High$17.51 / $38.49
Market Cap$1.09B

Company Details

Arcutis Biotherapeutics, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology. The company is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. Arcutis' robust pipeline includes four novel drug candidates currently in development for a range of inflammatory dermatological conditions. The company's lead product candidate, topical roflumilast, has the potential to become the standard of care for plaque psoriasis, atopic dermatitis, scalp psoriasis, and seborrheic dermatitis.
OrganisationArcutis Biotherapeutics Inc
Employees54
IndustryHealth Technology

Discover more

Frequently Asked Questions

What is Arcutis Biotherapeutics Inc (ARQT) share price today?

Can Indians buy Arcutis Biotherapeutics Inc (ARQT) shares?

How can I buy Arcutis Biotherapeutics Inc (ARQT) shares from India?

Can Fractional shares of Arcutis Biotherapeutics Inc (ARQT) be purchased?

What are the documents required to start investing in Arcutis Biotherapeutics Inc (ARQT) stocks?

We are a SEBI registered investement advisor